Table 5.

Clinical factors of mortality within 30 days.

	Univariate analysis			Multivariate analysis
Variable	Survival (n0 =0 48)	Mortality (n0 =0 11)	P-value	Odds ratio	95% CI	P-value
Age (years)	66.60 ± 0 17.2	63.80 ± 0 17.0	.991
Male	35 (72.9)	7 (63.6)	.542
Liver cirrhosis	3 (6.3)	4 (36.4)	.013	2.00	0.32–12.33	.455
Renal failure (CRF and ESRD)	11 (22.9)	2 (18.2)	.747
Malignant bleeding	5 (10.4)	2 (18.2)	.478
Coagulopathy*	12 (25)	10 (90.9)	.002	24.00	2.56–225.32	.005
Medication†	12 (25)	1 (9.1)	.274
Shock	35 (72.9)	10 (90.9)	.232
Embolization time (>24 h)	16 (33.3)	4 (36.4)	.848
Bleeding site (MGI or LGI vs UGI)	26 (54.2)	5 (45.5)	.603
≥ 2 territories embolization	3 (6.3)	3 (27.3)	.056
Multiple embolic agents	12 (25)	3 (27.3)	.876
Rebleeding (≤30 days)	15 (31.3)	7 (63.6)	.054
Massive transfusion‡	9 (18.8)	4 (36.4)	.213